The British Society for Immunology is delighted to celebrate International Day of Immunology by announcing a new partnership with the National Cancer Research Institute (NCRI) to bring our two communities together to drive collaborations to address current challenges in immunotherapy through a series of joint initiatives. The NCRI and BSI plan to work together to establish a series of joint initiatives that aim to accelerate the progress of immunotherapy in cancer. This will include enhancing the training for researchers and promoting knowledge sharing, identifying the challenges currently hindering progress in cancer immunotherapy and the formation of strategic research groups to address key research questions.
Dr Iain Frame, CEO of NCRI says: “The BSI is the largest immunology society in Europe with over 3500 members representing the diverse community of people working in immunology. They are the ideal partner for the NCRI to work with to accelerate research in this important area and unravel the interaction between the immune system and cancer to advance immunotherapy for all cancers.”
Dr Doug Brown, CEO of BSI says: “Cancer immunotherapy is an exciting and innovative area of immunology. Although we have taken significant steps forward over the last decade in bringing the first immunotherapies into frontline patient care, many challenges and opportunities still remain. Our collaboration with the NCRI, a partnership of cancer research funders who work together to accelerate research progress, is a brilliant opportunity to facilitate dialogue and collaboration between the immunology and cancer communities, speeding up discovery and knowledge transfer to bring positive change to the lives of people living with cancer.”
Our President, Professor Arne Akbar, has written a blog to explain more about the rationale behind this partnership and what we hope to achieve for the field of cancer immunotherapy.
We hope to bring you more news on this exciting initiative soon, but if you have any questions or would like more information about this partnership, contact email@example.com or firstname.lastname@example.org